{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:43:27Z","timestamp":1790516607279,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.humimm.2011.07.308","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T22:31:32Z","timestamp":1312410692000},"page":"1001-1006","source":"Crossref","is-referenced-by-count":34,"title":["Programmed death-1 (PD-1)\/PD-1 ligand pathway\u2013mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy\/tropical spastic paraparesis and carriers with autoimmune disorders"],"prefix":"10.1016","volume":"72","author":[{"given":"Tomohiro","family":"Kozako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakushi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomichi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2011.07.308_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","article-title":"Human T cell leukemia virus type I (HTLV-I) and human diseases","volume":"15","author":"Uchiyama","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humimm.2011.07.308_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/300063a0","article-title":"The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group","volume":"300","author":"Popovic","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2011.07.308_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2011.07.308_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2011.07.308_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humimm.2011.07.308_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.humimm.2011.07.308_bib7","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2008-06-163071","article-title":"HTLV-1 infection: role of CTL efficiency","volume":"112","author":"Bangham","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.07.308_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7883\/yoken.52.106","article-title":"Retroviruses and autoimmune diseases","volume":"52","author":"Matano","year":"1999","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.humimm.2011.07.308_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(89)90038-X","article-title":"Chronic inflammatory arthropathy associated with HTLV-I","volume":"1","author":"Nishioka","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2011.07.308_bib10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(94)90630-0","article-title":"Prevalence of serum and salivary antibodies to HTLV-1 in Sj\u00f6gren's syndrome","volume":"344","author":"Terada","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2011.07.308_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0140-6736(88)92744-4","article-title":"T-lymphocyte alveolitis, tropical spastic paresis, and Sjogren syndrome","volume":"1","author":"Vernant","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2011.07.308_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.6153243","article-title":"Chronic arthritis in goats caused by a retrovirus","volume":"207","author":"Crawford","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.humimm.2011.07.308_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.55.3.193","article-title":"High prevalence of arthropathy in HTLV-I carriers on a Japanese island","volume":"55","author":"Motokawa","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.humimm.2011.07.308_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/197197a0","article-title":"Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice","volume":"197","author":"Helyer","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2011.07.308_bib15","first-page":"1841","article-title":"Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus","volume":"34","author":"Akimoto","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.humimm.2011.07.308_bib16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.1887217","article-title":"Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I","volume":"253","author":"Iwakura","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.humimm.2011.07.308_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/341072a0","article-title":"Exocrinopathy resembling Sj\u00f6gren's syndrome in HTLV-1 tax transgenic mice","volume":"341","author":"Green","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2011.07.308_bib18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI115436","article-title":"Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy","volume":"88","author":"Kitajima","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humimm.2011.07.308_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0889-857X(21)00199-X","article-title":"Rheumatic manifestation of human leukemia virus infection","volume":"19","author":"Nishioka","year":"1993","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.humimm.2011.07.308_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.51.6.769","article-title":"Primary Sj\u00f6gren's syndrome with antibodies to HTLV-I: clinical and laboratory features","volume":"51","author":"Eguchi","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.humimm.2011.07.308_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1067\/mlc.2000.103429","article-title":"Relationship between Sj\u00f6gren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients","volume":"135","author":"Nakamura","year":"2000","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.humimm.2011.07.308_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/ard.56.3.167","article-title":"High prevalence of Sj\u00f6gren's syndrome in patients with HTLV-I associated myelopathy","volume":"56","author":"Nakamura","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.humimm.2011.07.308_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humimm.2011.07.308_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00262-006-0272-1","article-title":"Contribution of the PD-L1\/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion","volume":"56","author":"Blank","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.humimm.2011.07.308_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.humimm.2011.07.308_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.febslet.2004.07.083","article-title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70\/CD3zeta signalosome and downstream signaling to PKCtheta","volume":"574","author":"Sheppard","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.humimm.2011.07.308_bib27","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.4049\/jimmunol.177.8.5718","article-title":"Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients","volume":"177","author":"Kozako","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2011.07.308_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/leu.2008.272","article-title":"PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients","volume":"23","author":"Kozako","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2011.07.308_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1248\/yakushi.131.1061","article-title":"New strategy of adult T-cell leukemia treatment targeted for anti-tumor immunity and a longevity gene-encoded protein","volume":"131","author":"Kozako","year":"2011","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.humimm.2011.07.308_bib30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1742-4658.2011.08055.x","article-title":"Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant","volume":"278","author":"Kozako","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.humimm.2011.07.308_bib31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jmv.20807","article-title":"Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers","volume":"79","author":"Akimoto","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.humimm.2011.07.308_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.21985","article-title":"Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders","volume":"83","author":"Kozako","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.humimm.2011.07.308_bib33","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1099\/vir.0.19334-0","article-title":"The immune control and cell-to-cell spread of human T-lymphotropic virus type 1","volume":"84","author":"Bangham","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.humimm.2011.07.308_bib34","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2002-08-2477","article-title":"Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM\/TSP)","volume":"101","author":"Kubota","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.07.308_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/blood.V99.1.88","article-title":"Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP)","volume":"99","author":"Yamano","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.07.308_bib36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/infdis\/jiq153","article-title":"Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection","volume":"203","author":"Abdelbary","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.humimm.2011.07.308_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exphem.2003.11.008","article-title":"HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells","volume":"32","author":"Arima","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.humimm.2011.07.308_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","article-title":"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control","volume":"19","author":"Yoshida","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humimm.2011.07.308_bib39","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/blood-2008-02-138529","article-title":"Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease","volume":"112","author":"Enose-Akahata","year":"2008","journal-title":"Blood"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885911004782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885911004782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T13:55:51Z","timestamp":1638194151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885911004782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0198885911004782"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2011.07.308","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}